Cyclooxygenase-2: A Therapeutic Target
Tóm tắt
▪ Abstract Cyclooxygenase (COX), also known as prostaglandin endoperoxide synthase, is the key enzyme required for the conversion of arachidonic acid to prostaglandins. Two COX isoforms have been identified, COX-1 and COX-2. In many situations, the COX-1 enzyme is produced constitutively (e.g., in gastric mucosa), whereas COX-2 is highly inducible (e.g., at sites of inflammation and cancer). Traditional nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit both enzymes, and a new class of COX-2 selective inhibitors (COXIBs) preferentially inhibit the COX-2 enzyme. This review summarizes our current understanding of the role of COX-1 and COX-2 in normal physiology and disease.
Từ khóa
Tài liệu tham khảo
Vane JR, 1971, Nature, 231, 232
Needleman P, 1997, J. Rheumatol., 24, 6
Kang RY, 1996, Br. J. Cancer, 35, 711
Crofford LJ, 1997, J. Rheumatol., 24, 15
Pelletier JP, 1999, J. Rheumatol., 26, 2002
Cherng CH, 1996, Acta Anaesthesiol. Sinica, 34, 81
Lane NE, 1997, J. Rheumatol., 24, 20
Reicin A, 2001, Am. J. Orthop., 30, 40
Dunn MJ, 1977, Am. J. Physiol., 233, 169
Pugliese F, 1984, Clin. Exp. Rheumatol., 2, 345
Brzozowski T, 2000, J. Physiol. Pharmacol., 51, 751
Sun WH, 2000, J. Pharmacol. Exp. Ther., 295, 447
Thun MJ, 1993, Cancer Res., 53, 1322
Kawamori T, 1998, Cancer Res., 58, 409
Kargman S, 1995, Cancer Res., 55, 2556
Sano H, 1995, Cancer Res., 55, 3785
Williams CS, 2000, Cancer Res., 60, 6045
Piazza GA, 1995, Cancer Res., 55, 3110
Thompson HJ, 1997, Cancer Res., 57, 267
Piazza GA, 1997, Cancer Res., 57, 2452
Jacoby RF, 2000, Cancer Res., 60, 5040
Oshima M, 2001, Cancer Res., 61, 1733
Daniel TO, 1999, Cancer Res., 59, 4574
Wolff H, 1998, Cancer Res., 58, 4997
Grubbs CJ, 2000, Cancer Res., 60, 5599
Denkert C, 2001, Cancer Res., 61, 303
Zimmermann KC, 1999, Cancer Res., 59, 198
Shamma A, 2000, Clin. Cancer Res., 6, 1229
Hendel J, 1997, Am. J. Gastroenterol., 92, 1170